Back
Allogene Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
ALLO
Allogene Therapeutics
Last Price:
$1.24
Seasonality Move:
-16.36%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and ALLO is experiencing slight selling pressure.
Allogene Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.23 | Sell |
| 20-day SMA: | 1.22 | Buy |
| 50-day SMA: | 1.23 | Sell |
| 200-day SMA: | 1.88 | Sell |
| 8-day EMA: | 1.24 | Sell |
| 20-day EMA: | 1.24 | Sell |
| 50-day EMA: | 1.29 | Sell |
| 200-day EMA: | 1.83 | Sell |
Allogene Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 48.11 | Sell |
| Chaikin Money Flow: | -1087623 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.18 - 1.34) | Sell |
| Bollinger Bands (100): | (1.14 - 1.78) | Sell |
Allogene Therapeutics Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Allogene Therapeutics Stock
Is Allogene Therapeutics Stock a Buy?
-
Allogene Therapeutics share price is 1.23 while ALLO 8-day simple moving average is 1.23, which is a Sell signal.
-
The stock price of ALLO is 1.23 while Allogene Therapeutics 20-day SMA is 1.22, which makes it a Buy.
-
Allogene Therapeutics 50-day simple moving average is 1.23 while ALLO share price is 1.23, making it a Sell technically.
-
ALLO stock price is 1.23 and Allogene Therapeutics 200-day simple moving average is 1.88, creating a Sell signal.
ALLO Technical Analysis vs Fundamental Analysis
Sell
34
Allogene Therapeutics (ALLO)
is a Sell
Is Allogene Therapeutics a Buy or a Sell?
-
Allogene Therapeutics stock is rated a SellThe current Allogene Therapeutics [ALLO] share price is $1.23. The Score for ALLO is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Allogene Therapeutics Stock Info
Market Cap:
269M
Price in USD:
1.23
Share Volume:
2.2M
Allogene Therapeutics 52-Week Range
52-Week High:
3.78
52-Week Low:
0.86
Sell
34
Allogene Therapeutics (ALLO)
is a Sell
Allogene Therapeutics Share Price Forecast
-
What is the Allogene Therapeutics stock price today?The Allogene Therapeutics stock price is 1.23 USD today.
-
Will ALLO stock go up or go down?Allogene Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Allogene Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Allogene Therapeutics is overvalued.
Is Allogene Therapeutics Stock a Buy?
-
Allogene Therapeutics share price is 1.23 while ALLO 8-day exponential moving average is 1.24, which is a Sell signal.
-
The stock price of ALLO is 1.23 while Allogene Therapeutics 20-day EMA is 1.24, which makes it a Sell.
-
Allogene Therapeutics 50-day exponential moving average is 1.29 while ALLO share price is 1.23, making it a Sell technically.
-
ALLO stock price is 1.23 and Allogene Therapeutics 200-day simple moving average is 1.83, creating a Sell signal.
Fundamental Analysis of Allogene Therapeutics
Is Allogene Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.31 per share, and an increase next year of $0.00 per share.
Technical Analysis of Allogene Therapeutics
Should I short Allogene Therapeutics stock?
-
ALLO Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Allogene Therapeutics is a Sell
-
Allogene Therapeutics Relative Strength Index (RSI) is 48.11, which suggest Allogene Therapeutics is oversold
-
The Bollinger Bands (25) for Allogene Therapeutics is (1.18 - 1.34), which suggest Allogene Therapeutics is a Sell
-
The Bollinger Bands (100) for Allogene Therapeutics is (1.14 - 1.78), which suggest Allogene Therapeutics is a Sell
* Allogene Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.